shortagewatch

Home / Cancer and immune system / Bevacizumab

ATC L01FG01 · Antineoplastic Agents

Bevacizumab shortage

As of 31 Oct 2026, Bevacizumab has a reported shortage in 1 of the 5 countries we track (Italy), covering 3 products.

Countries1/5
Products3packs or presentations
Short since8 Feb 20269 months ago
Earliest returnnot givencompany estimate
No return date3products
Main reasonIncreased demand
GermanyNo reported shortageItaly3 packs shortSpainNo reported shortageAustriaNo reported shortageBelgiumNo reported shortage

Timeline

Italy
AYBINTIOAYBINTIOAYBINTIOAYBINTIOVEGZELMAVEGZELMAtoday

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Affected products

CountryProductHolderSinceExpected backReason
ITAYBINTIOSAMSUNG BIOEPIS NL B.V.8 Feb 2026not givenIncreased demand
Elevata richiesta
ITAYBINTIOSAMSUNG BIOEPIS NL B.V.21 Feb 2026not givenIncreased demand
Elevata richiesta
ITVEGZELMACELLTRION HEALTHCARE HUNGARY KFT1 May 2026not givenIncreased demand
Elevata richiesta

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.